JP5385532B2 - 脊柱癒着の防止において使用される、硫酸化ヒアルロン酸とゲランとからなるバイオマテリアル - Google Patents

脊柱癒着の防止において使用される、硫酸化ヒアルロン酸とゲランとからなるバイオマテリアル Download PDF

Info

Publication number
JP5385532B2
JP5385532B2 JP2007535074A JP2007535074A JP5385532B2 JP 5385532 B2 JP5385532 B2 JP 5385532B2 JP 2007535074 A JP2007535074 A JP 2007535074A JP 2007535074 A JP2007535074 A JP 2007535074A JP 5385532 B2 JP5385532 B2 JP 5385532B2
Authority
JP
Japan
Prior art keywords
hyaluronic acid
sulfated hyaluronic
sulfated
gellan
biomaterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007535074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515832A5 (enExample
JP2008515832A (ja
Inventor
ベッリーニ，ダヴィデ
ロンギノッティ，クリスティーナ
クレシェンツィ，ヴィットーリオ
タグリエンティ，アンナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anika Therapeutics SRL
Original Assignee
Anika Therapeutics SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anika Therapeutics SRL filed Critical Anika Therapeutics SRL
Publication of JP2008515832A publication Critical patent/JP2008515832A/ja
Publication of JP2008515832A5 publication Critical patent/JP2008515832A5/ja
Application granted granted Critical
Publication of JP5385532B2 publication Critical patent/JP5385532B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2007535074A 2004-10-08 2005-10-03 脊柱癒着の防止において使用される、硫酸化ヒアルロン酸とゲランとからなるバイオマテリアル Expired - Lifetime JP5385532B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPD2004A000245 2004-10-08
IT000245A ITPD20040245A1 (it) 2004-10-08 2004-10-08 Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
PCT/EP2005/010645 WO2006037592A1 (en) 2004-10-08 2005-10-03 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

Publications (3)

Publication Number Publication Date
JP2008515832A JP2008515832A (ja) 2008-05-15
JP2008515832A5 JP2008515832A5 (enExample) 2008-11-20
JP5385532B2 true JP5385532B2 (ja) 2014-01-08

Family

ID=35610035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007535074A Expired - Lifetime JP5385532B2 (ja) 2004-10-08 2005-10-03 脊柱癒着の防止において使用される、硫酸化ヒアルロン酸とゲランとからなるバイオマテリアル

Country Status (12)

Country Link
US (2) US8563039B2 (enExample)
EP (1) EP1796752B1 (enExample)
JP (1) JP5385532B2 (enExample)
KR (1) KR20070107658A (enExample)
CN (1) CN101035575B (enExample)
AU (1) AU2005291474B2 (enExample)
BR (1) BRPI0516568A (enExample)
CA (1) CA2583149C (enExample)
IT (1) ITPD20040245A1 (enExample)
MX (1) MX2007004158A (enExample)
RU (1) RU2383336C2 (enExample)
WO (1) WO2006037592A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20050206A1 (it) * 2005-07-07 2007-01-08 Fidia Advanced Biopolymers Srl Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione
JP5088864B2 (ja) * 2007-03-16 2012-12-05 オリンパス株式会社 生体組織補填材とその製造方法
CA2719666C (en) 2008-04-04 2016-08-16 Glenn Prestwich Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
EP2280739B1 (en) * 2008-06-03 2012-07-04 Actamax Surgical Materials LLC A tissue coating for preventing undesired tissue-to-tissue adhesions
EP2387390B1 (en) 2009-01-13 2012-11-28 PharmaSurgics in Sweden AB Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
IT1397247B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi agenti regolatori dell'attivita' citochinica
EP2688402B1 (en) 2011-03-23 2018-10-24 University of Utah Research Foundation Means for treating or preventing urological inflammation
ITMI20120664A1 (it) 2012-04-20 2013-10-21 Anika Therapeutics Srl Biomateriali a base di gellano per l'uso come filler in chirurgia
ITMI20130221A1 (it) * 2013-02-18 2014-08-19 Novagenit S R L Formulazione a base di polisaccaridi biocompatibili e biodegradabili da impiegare in chirurgia
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
US10590257B2 (en) 2016-09-26 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications
US11969526B2 (en) 2017-04-03 2024-04-30 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US11975123B2 (en) 2018-04-02 2024-05-07 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
WO2020072495A1 (en) 2018-10-01 2020-04-09 The Board Of Trustees Of The Leland Stanford Junior University Injectable hydrogels for controlled release of immunomodulatory compounds
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
RU2744752C1 (ru) * 2020-08-28 2021-03-15 Федеральное государственное бюджетное учреждение науки Институт проблем химико-энергетических технологий Сибирского отделения Российской академии наук (ИПХЭТ СО РАН) Способ получения противоспаечного материала

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326053A (en) * 1978-12-04 1982-04-20 Merck & Co., Inc. Polysaccharide S-60 and bacterial fermentation process for its preparation
US5080893A (en) * 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
CN1301139C (zh) * 1995-08-29 2007-02-21 菲迪亚高级生物聚合物公司 包括透明质酸衍生物的用于预防手术后粘连的生物材料
SE9603480L (sv) * 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
AU738788B2 (en) * 1997-04-04 2001-09-27 Fidia Farmaceutici S.P.A. N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
IT1294797B1 (it) * 1997-07-28 1999-04-15 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
US20030219431A1 (en) * 2002-05-24 2003-11-27 Empire Pharmaceuticals, Inc. Treatment of neuronal and neurological damage associated with spinal cord injury

Also Published As

Publication number Publication date
BRPI0516568A (pt) 2008-09-09
AU2005291474B2 (en) 2011-06-02
RU2007112777A (ru) 2008-10-10
RU2383336C2 (ru) 2010-03-10
ITPD20040245A1 (it) 2005-01-08
CN101035575A (zh) 2007-09-12
CA2583149C (en) 2013-09-10
EP1796752B1 (en) 2012-12-12
US20090202639A1 (en) 2009-08-13
US20130184234A1 (en) 2013-07-18
EP1796752A1 (en) 2007-06-20
CA2583149A1 (en) 2006-04-13
KR20070107658A (ko) 2007-11-07
AU2005291474A1 (en) 2006-04-13
JP2008515832A (ja) 2008-05-15
MX2007004158A (es) 2007-10-08
WO2006037592A1 (en) 2006-04-13
CN101035575B (zh) 2011-12-14
US8563039B2 (en) 2013-10-22
US8728524B2 (en) 2014-05-20

Similar Documents

Publication Publication Date Title
US8728524B2 (en) Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
Gilarska et al. Collagen/chitosan/hyaluronic acid–based injectable hydrogels for tissue engineering applications–design, physicochemical and biological characterization
JP5746617B2 (ja) キトサン混合物を形成する注入可能なヒドロゲル
Rodríguez-Vázquez et al. Chitosan and its potential use as a scaffold for tissue engineering in regenerative medicine
Mao et al. A preliminary study on chitosan and gelatin polyelectrolyte complex cytocompatibility by cell cycle and apoptosis analysis
KR100674177B1 (ko) 교차 결합된 히알루론산과 그것의 의학적 용도
Chang et al. Citric acid crosslinked sphingan WL gum hydrogel films supported ciprofloxacin for potential wound dressing application
Li et al. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention
Wei et al. Injectable hydrogel based on dodecyl-modified N-carboxyethyl chitosan/oxidized konjac glucomannan effectively prevents bleeding and postoperative adhesions after partial hepatectomy
Wei et al. A thermosensitive chitosan-based hydrogel barrier for post-operative adhesions' prevention
Kaczmarek-Pawelska Alginate-based hydrogels in regenerative medicine
Cai et al. Physically cross-linked hyaluronan-based ultrasoft cryogel prepared by freeze–thaw technique as a barrier for prevention of postoperative adhesions
Huang et al. Thermosensitive hydrogels based on methylcellulose derivatives for prevention of postoperative adhesion
AU708758B2 (en) Anti-adhesion agent
Rezakhani et al. Recent advances in hydrogels applications for tissue engineering and clinical trials
US6486140B2 (en) Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site
CN110038161A (zh) 一种新型透明质酸流动凝胶及其制备方法和应用
JP2004181121A (ja) 軟骨組織再生用注入剤組成物
Sudha et al. Advances in guar gum-based materials in biomedical applications with special reference to tissue engineering applications
Prasannavenkadesan et al. 4 Chitosan in orthopedics: current advancements and future prospects
HK1107031A (en) Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
Dik et al. Polymer-based anti-adhesive barriers: A comprehensive overview of current approaches for medical and biological applications
Shalaby et al. Hyaluronic Acid-Based Systems

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080930

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111025

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120823

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120830

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120925

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120926

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121002

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121204

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130801

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130813

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130924

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131004

R150 Certificate of patent or registration of utility model

Ref document number: 5385532

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250